Targeting PARP11 to Avert Immunosuppression and Improve CAR T Therapy in Solid Tumors

The authors found that tumor microenvironment factors, such as regulatory T cells and adenosine, downregulated type I interferon receptor IFNAR1 on CD8+ cytotoxic T lymphocytes. (CTLs).